New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC)
- PMID: 16608978
- DOI: 10.1093/annonc/mdj918
New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC)
Abstract
Local control is a main step to cure NSCLC because at least 30-40% of patients die for local or regional progression of their disease. Surgery is still the more efficient approach to increase survival but radiation therapy is the only treatment that can cure patients with T1-T2 lesions if they are not suitable for surgery or refuse it. However, doses higher than 60-66 Gy must be given to improve tumor control but doses to the organs at risk (OAR) are the main limit to deliver more than 70 Gy to the planning treatment volume (PTV). The optimal solution would be to 'paint' the dose to the PTV avoiding as possible OARs, but this ballistic precision was not possible till some years ago because of both technology and respiratory movement control. In last ten years many new techniques have been made available for treating NSCLC with radiation more accurately. Some techniques like Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Stereotactic Radiotherapy can be carried out also with a traditional linear accelerator (LINAC) updated with the new software and hardware, using or not radiopaque markers inside the tumor. On the other hand, a new generation of machines like Cyberknife or Tomotherapy have been especially projected to optimize stereotactic technique and IMRT, respectively, and respiratory gating systems are now disposable from several manufactures.
Similar articles
-
A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.Radiother Oncol. 2007 May;83(2):156-62. doi: 10.1016/j.radonc.2007.04.005. Epub 2007 May 9. Radiother Oncol. 2007. PMID: 17493699
-
Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.Strahlenther Onkol. 2017 Oct;193(10):780-790. doi: 10.1007/s00066-017-1151-8. Epub 2017 May 31. Strahlenther Onkol. 2017. PMID: 28567503 English.
-
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.Radiat Oncol. 2019 Jun 13;14(1):106. doi: 10.1186/s13014-019-1259-3. Radiat Oncol. 2019. PMID: 31196118 Free PMC article.
-
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer.Radiother Oncol. 2000 Aug;56(2):157-67. doi: 10.1016/s0167-8140(00)00207-3. Radiother Oncol. 2000. PMID: 10927134 Review.
-
New approaches to radiotherapy as definitive treatment for inoperable lung cancer.Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):188-97. doi: 10.1053/j.semtcvs.2008.09.003. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038727 Review.
Cited by
-
Survival analysis and clinicopathological features of patients with stage IA lung adenocarcinoma.Heliyon. 2023 Dec 6;10(1):e23205. doi: 10.1016/j.heliyon.2023.e23205. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38169765 Free PMC article.
-
Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.Pract Radiat Oncol. 2016 May-Jun;6(3):e73-e80. doi: 10.1016/j.prro.2015.10.004. Epub 2015 Oct 22. Pract Radiat Oncol. 2016. PMID: 26725964 Free PMC article.
-
Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?Cureus. 2016 Jan 23;8(1):e466. doi: 10.7759/cureus.466. Cureus. 2016. PMID: 26929893 Free PMC article.
-
Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma.Radiat Oncol. 2011 Jul 20;6:84. doi: 10.1186/1748-717X-6-84. Radiat Oncol. 2011. PMID: 21771344 Free PMC article.
-
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects.Nat Rev Clin Oncol. 2016 Oct;13(10):611-26. doi: 10.1038/nrclinonc.2016.57. Epub 2016 Apr 26. Nat Rev Clin Oncol. 2016. PMID: 27118493 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical